Sculptor Capital’s ResMed RMD Stock Holding History

Sculptor Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-250,000	Closed	-$12.3M	–	821
2014 Q3	$12.3M	Buy	250,000 +30,000	+14%	+$1.53M	0.04%	343
2014 Q2	$11.1M	Hold	220,000	–	–	0.03%	378
2014 Q1	$9.83M	Buy	220,000 +50,000	+29%	+$2.25M	0.03%	384
2013 Q4	$8M	Sell	170,000 -50,000	-23%	-$2.53M	0.02%	492
2013 Q3	$11.6M	Buy	+220,000	New	+$10.7M	0.03%	432

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sculptor Capital's RMD Position: Q4 2014 in Review

Sculptor Capital sold out of ResMed (RMD) in Q4 2014, closing a stake of 89,998 shares — an estimated $4.43M sold.

Sculptor Capital first reported a position in RMD in Q3 2013 and held it in 5 quarters. The position peaked at $8M in Q4 2013. 308 funds tracked by Wall St. Rank hold RMD as of Q4 2014.

Sculptor Capital reported no remaining ResMed position as of Q4 2014 after selling out during the quarter.
Sculptor Capital sold 89,998 ResMed shares in Q4 2014, an estimated $4.43M.
Sculptor Capital first reported a position in ResMed in Q3 2013 and held it in 5 quarters.
Sculptor Capital's ResMed position peaked at $8M in Q4 2013.
308 funds tracked by Wall St. Rank held ResMed as of Q4 2014.

Based on Sculptor Capital's 13F filing for Q4 2014, filed 17 Feb 2015.